The independent source for health policy research, polling, and news.
The Senate’s secret deliberation on the health bill overhaul is part of a long, slow slide away from transparency. And I’m a witness.
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter.
The North Carolina Harm Reduction Coalition has advanced a local shift from a tough-on-drugs approach to harm-reduction philosophy. Other red states signal they may follow suit.
In Pennsylvania alone, 124,000 people received drug or alcohol addiction treatment through Medicaid. Republicans in Congress want to cut Medicaid by as much as $800 billion over the next decade, leaving people in recovery wondering what will happen to their treatment.
States are not doing enough to help elderly and disabled Medicaid enrollees receive services in homes and community locations instead of in nursing homes, where care is more expensive, AARP report says.
With lots of questions about the 2018 insurance market still in play, someone who is between jobs might want to stick with their job-based insurance at least until the outlines of the health law’s marketplaces are clear in the fall.
So far, 72 affected babies have been born in the continental U.S. One young mother, infected in Mexico last year, and her infant face an uncertain future in rural Washington.
Across the U.S., the number of teenagers having babies has hit a record low — it’s down to about 1 out of every 45 young women. That trend hasn’t extended to certain parts of Texas, however, where the teen birth rate is still nearly twice the national average.
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
At least 500 terminally ill Californians have asked for the medicine that allows them to end their lives, and nearly 500 health organizations have signed on to help.
The researchers looked at 11 services that medical groups have said are often unnecessary and found that Hispanics and blacks got them at higher rates than whites.
One of two insurers in this tiny state has announced it will not be back in the marketplaces next year, leaving customers concerned about the prices they will pay.
Tom Price defends proposed spending reductions in Medicaid and other HHS programs while demurring on questions about cost-sharing subsidies for the 2018 Obamacare marketplace.
Actions by the Trump administration are putting pressure on the fragile market for individuals who buy their own coverage, but analysts say it should be able to rebound.
Corinne Bobbie has a love-hate relationship with the Affordable Care Act. As the GOP tries to repeal the law, the experiences and fears of voters like Bobbie could determine a politician’s fate.
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
The Obamacare replacement bill passed by House Republicans would cut Medicaid by $834 billion over a decade. That has people with disabilities scared that services that allow them to live independently, such as job training and transportation, will disappear.
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial — and expensive — immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
